Dublin, March 11, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/7xlxzb/ingestible_sensor) has announced the addition of the "Ingestible Sensor Market - Global Forecast to 2022" report to their offering.
The ingestible sensor market size is expected to grow from USD 198.2 Million in 2015 to USD 678.2 Million by 2022, at a CAGR of 20.2% between 2016 and 2022. The growing need for medication adherence, increasing rate of chronic diseases, and demand for real-time monitoring create a huge demand for ingestible sensors across the world.
The growing complexities in diagnosing and managing chronic diseases and other biomedical activities are creating opportunities for the ingestible sensor market. The expansion of ingestible sensors in novel medical applications such as customized drug delivery is also responsible for contributing to the overall ingestible sensor market. Patients are found to be comfortable and prefer minimally invasive techniques for diagnosis and monitoring. Moreover, ingestible sensors are more accurate than the traditional medical equipment.
Therefore, these sensors are in high demand in the medical vertical. In other verticals such as sports, astronauts, animal care, mining, fire-fighting, and military, ingestible sensors are used to signify the core body temperature changes in relation with the extreme working environment. Thus, this market has a great scope for growth in the next five years.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
7 Ingestible Sensors Market, By Component
8 Ingestible Sensors Market, By Sensor Type
9 Ingestible Sensors Market, By Vertical
10 Geographical Analysis
11 Competitive Landscape
12 Company Profiles
Companies Mentioned:
- Capsovision Inc.
- Given Imaging Ltd
- HQ, Inc.
- MC10, Inc.
- Medimetrics Personalized Drug Delivery B.V.
- Microchips Biotech, Inc.
- Olympus Corporation
- Proteus Digital Health, Inc.
For more information visit http://www.researchandmarkets.com/research/7xlxzb/ingestible_sensor
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Medical Devices, Sports Medicine , Capacitive Sensors , Temperature and Heat Sensors


Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
China’s Iron Ore Buyer Pressures Mining Giants as New Supply Shifts Market Power
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Boeing Secures Multi-Billion Dollar Defense Contracts for F-15IA Jets and E-4B Aircraft Support
Lockheed Martin Secures $92.8M AEGIS Sustainment Contract from U.S. Navy
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions 



